Coronary microvascular dysfunction in patients with diabetes, hypertension and metabolic syndrome

International Journal of Cardiology

Volumn 186, Issue , 2015, Pages 96-97

  Sucato, Vincenzo ^a   Novo, Giuseppina ^a   Evola, Salvatore ^a   Novo, Salvatore ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Diabetes; Hypertension; Metabolic syndrome; Microvascular dysfunction

Indexed keywords

ADVANCED GLYCATION END PRODUCT; C REACTIVE PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEPTIN; LOW DENSITY LIPOPROTEIN RECEPTOR; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; BLOOD VESSEL DIAMETER; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY MICROVASCULAR DYSFUNCTION; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; GENE DELETION; GLYCEMIC CONTROL; HEART MUSCLE FIBROSIS; HEART MUSCLE PERFUSION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LETTER; METABOLIC SYNDROME X; MICROANGIOPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYNDROME X; COMPLICATION; CORONARY ARTERY BLOOD FLOW; PATHOPHYSIOLOGY; PHYSIOLOGY;

CORONARY ARTERY DISEASE; CORONARY CIRCULATION; DIABETES MELLITUS; HUMANS; HYPERTENSION; METABOLIC SYNDROME X;

EID: 84929179344     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.213     Document Type: Article

References (10)

1. G.A. Lanza, and F. Crea Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management Circulation 121 2010 2317 2325
2. V. Sucato, S. Evola, G. Novo, E. Bronte, and S. Novo Stable microvascular angina: instrumental evaluation of coronary microvascular dysfunction with coronary angiography and myocardial scintigraphy Int. J. Cardiol. 171 3 2014 e127 e128
3. A. Vasheghani-Farahani, N. Nouri, S. Seifirad, M. Sheikh Fathollahi, E. Hakki, and M. Alidoosti Comparison of cardiovascular risk factors and biochemical profile in patients with cardiac syndrome X and obstructive coronary artery disease: a propensity score-matched study ARYA Atheroscler. 9 5 2013 269 273
4. M. Bottcher, He Botker, H. Sonne, T.T. Nielse, and J. Czernin Endothelium dependent and independent perfusion reserve and the effect of l-arginine on myocardial perfusion in patients with syndrome X Circulation 99 1999 1795 1801
5. O. Traub, and R. Van Bibber Role of nitric oxide in insulin-dependent diabetes mellitus-related vascular complications West. J. Med. 162 5 May 1995 439 445
6. T. Inoguchi, P. Li, and F. Umeda High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NADPH oxidase in cultured vascular cells Diabetes 49 2000 1939 1945
7. V. Sucato, S. Evola, and A. Quagliana Comparison of coronary artery flow impairment in diabetic and hypertensive patients with stable microvascular angina Eur. Rev. Med. Pharmacol. Sci. 18 23 2014 3687 3689
8. T. Ulus Statins improve myocardial perfusion in metabolic syndrome patients who have perfusion defects on myocardial perfusion imaging and angiographically normal coronary arteries Eur. Rev. Med. Pharmacol. Sci. 16 3 Mar 2012 328 334
9. N. Hermida HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome Cardiovasc. Res. 99 1 Jul 1 2013 44 54
10. A.J. Kientz Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease? J. Vasc. Res. 46 6 2009 515 526